Article ; Online: Solubility Enhancement of Antidiabetic Drugs Using a Co-Crystallization Approach.
2021 Volume 10, Issue 12, Page(s) 1260–1268
Abstract: The co-crystallization approach has been used to enhance specific desirable properties of active pharmaceutical ingredients (APIs) such as solubility, dissolution rate, and stability. Solubility is a fundamental property that affects the bioavailability ... ...
Abstract | The co-crystallization approach has been used to enhance specific desirable properties of active pharmaceutical ingredients (APIs) such as solubility, dissolution rate, and stability. Solubility is a fundamental property that affects the bioavailability and dosage of the API. The co-crystal approach is one of the emerging methods with the potential for improving the solubility of these drugs. This paper reviews the latest progress on improving the solubility of some antidiabetic drug molecules using the co-crystal approach. |
---|---|
MeSH term(s) | Biological Availability ; Crystallization ; Hypoglycemic Agents ; Solubility |
Chemical Substances | Hypoglycemic Agents |
Language | English |
Publishing date | 2021-12-18 |
Publishing country | Germany |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 2655605-4 |
ISSN | 2191-1363 ; 2191-1363 |
ISSN (online) | 2191-1363 |
ISSN | 2191-1363 |
DOI | 10.1002/open.202100246 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.